{"id":42365,"date":"2023-11-20T02:26:01","date_gmt":"2023-11-20T08:26:01","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/head-neck-cetuximab-pub\/"},"modified":"2023-11-20T02:26:01","modified_gmt":"2023-11-20T08:26:01","slug":"head-neck-cetuximab-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/head-neck-cetuximab-pub\/","title":{"rendered":"HEAD-NECK-CETUXIMAB-PUB"},"template":"","class_list":["post-42365","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p>Ang, K. K., Zhang, Q., Rosenthal, D. I., Nguyen-Tan, P. F., Sherman, E. J., Weber, R. S., Galvin, J. M., Bonner, J. A., Harris, J., El-Naggar, A. K., Gillison, M. L., Jordan, R. C., Konski, A. A., Thorstad, W. L., Trotti, A., Beitler, J. J., Garden, A. S., Spanos, W. J., Yom, S. S., &amp; Axelrod, R. S. (2014). <strong>Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522<\/strong>. In Journal of Clinical Oncology (Vol. 32, Issue 27, pp. 2940\u20132950). American Society of Clinical Oncology (ASCO). <a href=\"https:\/\/doi.org\/10.1200\/jco.2013.53.5633\">https:\/\/doi.org\/10.1200\/jco.2013.53.5633<\/a><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1200\/jco.2013.53.5633","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/42365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=42365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}